---
document_datetime: 2025-12-02 05:02:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/evotopin.html
document_name: evotopin.html
version: success
processing_time: 0.0437044
conversion_datetime: 2025-12-27 09:37:11.082785
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Evotopin

[RSS](/en/individual-human-medicine.xml/65775)

##### Withdrawn

This medicine's authorisation has been withdrawn

topotecan Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

The marketing authorisation for Evotopin has been withdrawn at the request of the marketing authorisation holder.

## Product information

31/12/2009

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

## Product details

Name of medicine Evotopin Active substance topotecan International non-proprietary name (INN) or common name topotecan Therapeutic area (MeSH) Ovarian Neoplasms Anatomical therapeutic chemical (ATC) code L01CE01

### Pharmacotherapeutic group

Antineoplastic agents

### Therapeutic indication

Topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.

## Authorisation details

EMA product number EMEA/H/C/000124 Marketing authorisation holder

Beecham Group plc

,

Marketing authorisation issued 15/04/1997

**This page was last updated on** 31/12/2009

## Share this page

[Back to top](#main-content)